1. Home
  2. LXU vs PRTC Comparison

LXU vs PRTC Comparison

Compare LXU & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$8.51

Market Cap

626.6M

Sector

Industrials

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.72

Market Cap

386.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LXU
PRTC
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
626.6M
386.7M
IPO Year
1969
N/A

Fundamental Metrics

Financial Performance
Metric
LXU
PRTC
Price
$8.51
$16.72
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$10.17
N/A
AVG Volume (30 Days)
445.0K
2.2K
Earning Date
10-29-2025
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.20
Revenue
$585,065,000.00
$6,391,000.00
Revenue This Year
$16.54
N/A
Revenue Next Year
$0.31
N/A
P/E Ratio
N/A
$8.13
Revenue Growth
12.49
1265.60
52 Week Low
$4.88
$13.30
52 Week High
$9.98
$20.00

Technical Indicators

Market Signals
Indicator
LXU
PRTC
Relative Strength Index (RSI) 40.84 48.97
Support Level $8.62 $16.75
Resistance Level $8.88 $17.85
Average True Range (ATR) 0.21 0.44
MACD -0.05 0.04
Stochastic Oscillator 12.68 34.80

Price Performance

Historical Comparison
LXU
PRTC

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: